Table of Contents
Chapter 1. Global Cell and Gene Therapy Market Executive Summary
1.1. Global Cell and Gene Therapy Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Therapy Type
1.3.2. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Cell and Gene Therapy Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Cell and Gene Therapy Market Dynamics
3.1. Market Drivers
3.1.1. Growing Incidences of Cancer and Rare Disorders
3.1.2. Increasing Approval for Gene and Cell Therapy Products
3.1.3. Growing Investments in the Field of Cell and Gene Therapy
3.2. Market Challenges
3.2.1. High Cost of Treatment
3.2.2. Complexity of Regulatory Approvals
3.3. Market Opportunities
3.3.1. Technological Advancements
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Cell and Gene Therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Cell and Gene Therapy Market Size & Forecasts by Therapy Type 2022-2032
5.1. Segment Dashboard
5.2. Global Cell and Gene Therapy Market: Therapy Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Cell Therapy
5.2.2. Gene Therapy
5.2.2.1. Autologous
5.2.2.2. Allogenic
5.2.2.3. Ex-vivo
5.2.2.4. In-vivo
Chapter 6. Global Cell and Gene Therapy Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Cell and Gene Therapy Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cancer
6.2.2. Neurological Disorders
6.2.3. Cardiovascular Disorders
6.2.4. Rare Diseases
6.2.5. Ophthalmology
6.2.6. Blood Disorders
6.2.7. Others
Chapter 7. Global Cell and Gene Therapy Market Size & Forecasts by Region 2022-2032
7.1. North America Cell and Gene Therapy Market
7.1.1. U.S. Cell and Gene Therapy Market
7.1.1.1. Therapy Type breakdown size & forecasts, 2022-2032
7.1.1.2. Application breakdown size & forecasts, 2022-2032
7.1.2. Canada Cell and Gene Therapy Market
7.2. Europe Cell and Gene Therapy Market
7.2.1. UK Cell and Gene Therapy Market
7.2.2. Germany Cell and Gene Therapy Market
7.2.3. France Cell and Gene Therapy Market
7.2.4. Spain Cell and Gene Therapy Market
7.2.5. Italy Cell and Gene Therapy Market
7.2.6. Rest of Europe Cell and Gene Therapy Market
7.3. Asia-Pacific Cell and Gene Therapy Market
7.3.1. China Cell and Gene Therapy Market
7.3.2. India Cell and Gene Therapy Market
7.3.3. Japan Cell and Gene Therapy Market
7.3.4. Australia Cell and Gene Therapy Market
7.3.5. South Korea Cell and Gene Therapy Market
7.3.6. Rest of Asia Pacific Cell and Gene Therapy Market
7.4. Latin America Cell and Gene Therapy Market
7.4.1. Brazil Cell and Gene Therapy Market
7.4.2. Mexico Cell and Gene Therapy Market
7.4.3. Rest of Latin America Cell and Gene Therapy Market
7.5. Middle East & Africa Cell and Gene Therapy Market
7.5.1. Saudi Arabia Cell and Gene Therapy Market
7.5.2. South Africa Cell and Gene Therapy Market
7.5.3. Rest of Middle East & Africa Cell and Gene Therapy Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novartis AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Bristol-Myers Squibb Company
8.3.3. Amgen Inc.
8.3.4. Aurion Biotech
8.3.5. Sarepta Therapeutics, Inc.
8.3.6. Ferring B.V.
8.3.7. Sibiono Genetech Co, Ltd., Shenzhen
8.3.8. Bluebird Bio, Inc.
8.3.9. Kite Pharmaceuticals, Inc.
8.3.10. Janssen Global Services
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes